Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Hyderabad is witnessing a rise in advanced-stage prostate cancer due to low screening rates and lifestyle factors. Experts ...

For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing ...

The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

Mordor Intelligence has published a new report on the prostate cancer market, offering a comprehensive analysis of trends, growth drivers, and future projections.

A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...

If you were to ask a group of men about prostate cancer, the conversation would likely begin with unease and end with uncertainty. It is one of those illnesses that ...

Clinical trial participation is associated with improved survival for patients with some genitourinary cancers, but racial, ethnic, age, gender, and socioeconomic disparities appe ...

Fred Hutch at AACR: Colorectal cancer and glyphosate exposure, potential therapeutic targets for ovarian cancer, a new molecular standard of care for cancer patients — and more ...

Most prostate cancers are initially diagnosed as localized disease and can be effectively treated with surgery or radiation therapy. However, a subset of ...

Queenslander Tony Gorry laced up to jog 72km in just one day during September, from Toorbul to the Story Bridge, in an effort ...